Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Receivables (2016 - 2026)

Argan (AGX) has disclosed Receivables for 16 consecutive years, with $177.1 million as the latest value for Q1 2026.

  • Quarterly Receivables fell 13.3% to $177.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $177.1 million through Jan 2026, down 13.3% year-over-year, with the annual reading at $177.1 million for FY2026, 13.3% down from the prior year.
  • Receivables hit $177.1 million in Q1 2026 for Argan, down from $208.8 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $208.8 million in Q4 2025 to a low of $31.9 million in Q1 2022.
  • Historically, Receivables has averaged $111.6 million across 5 years, with a median of $95.5 million in 2024.
  • Biggest five-year swings in Receivables: soared 394.1% in 2022 and later fell 13.3% in 2026.
  • Year by year, Receivables stood at $49.4 million in 2022, then surged by 52.3% to $75.3 million in 2023, then soared by 134.06% to $176.3 million in 2024, then increased by 18.44% to $208.8 million in 2025, then decreased by 15.19% to $177.1 million in 2026.
  • Business Quant data shows Receivables for AGX at $177.1 million in Q1 2026, $208.8 million in Q4 2025, and $202.9 million in Q3 2025.